| Name | Title | Contact Details |
|---|
American Medical Response (AMR) is the nation`s leading medical transportation company serving more than 4,000 communities nationwide, and providing more than 4.8 million emergency and non-emergency patient transports each year. Every 10 seconds, our extensive network of more than 29,000 EMTs, paramedics, nurses, physicians, dispatchers and other professionals touch the lives of someone in need.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Inspyr Therapeutics, Inc. is a biotechnology company focused on the development and commercialization of promising, new therapeutics. Our work is motivated by a commitment to innovation and helping patients. We combine our powerful insights and rigorous scientific methods to create new treatment options for patients.
Radiology Alliance, P.C. is a Nashville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MEDO USA is a Roselle, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.